MarketCap
Facebook
X
TelegramQuarterly report 2022-Q4
added 02-09-2023
Country |
 Schweiz |
IPO year |
2014 |
Industry |
Diagnostics research |
Stock Exchange |
NASDAQ GLOBAL |
Shares |
91.6 M |
Market Cap[1] |
$ 1.1 M |
EBITDA (LTM) |
$ -209 M |
P/E (LTM) |
- |
P/S (LTM) |
0.02 |
EPS (LTM) |
-71.8 |
Other stocks of industry "Diagnostics research"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
- | -6.23 % | $ 30.6 M | Nasdaq Global Market |  Germany |
 |
Fulgent Genetics
FLGT
|
$ 15.96 | 5.63 % | $ 483 M | Nasdaq Global Market |  USA |
 |
Burning Rock Biotech Limited
BNR
|
$ 16.76 | 1.09 % | $ 177 M | Nasdaq Global Market |  China |
 |
Castle Biosciences
CSTL
|
$ 19.83 | 3.07 % | $ 575 M | Nasdaq Global Market,SPB | USA |
 |
Agilent Technologies
A
|
$ 115.62 | -2.55 % | $ 35.1 B | NYSE,SPB | USA |
|
Akumin
AKU
|
- | -17.87 % | $ 25.9 M | Nasdaq Capital Market |  Canada |
 |
Aspira Women's Health
AWH
|
- | -6.19 % | $ 10.5 M | Nasdaq Capital Market,SPB | USA |
 |
Accelerate Diagnostics
AXDX
|
- | -61.36 % | $ 2.46 M | Nasdaq Global Select Market | USA |
 |
Biocept
BIOC
|
- | -13.05 % | $ 7.29 M | Nasdaq Capital Market | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
- | - | $ 562 M | Nasdaq Global Select Market |  Britain |
 |
CareDx, Inc
CDNA
|
$ 21.82 | 1.77 % | $ 1.16 B | Nasdaq Global Market,SPB | USA |
 |
Chembio Diagnostics
CEMI
|
- | 0.22 % | $ 16.8 M | Nasdaq Capital Market | USA |
 |
Check-Cap Ltd.
CHEK
|
- | - | $ 9.42 M | Nasdaq Capital Market |  Israel |
 |
Lantheus Holdings
LNTH
|
$ 93.06 | 2.26 % | $ 6.28 B | Nasdaq Global Select Market,SPB | USA |
 |
HTG Molecular Diagnostics
HTGM
|
- | -20.0 % | $ 1.06 M | Nasdaq Capital Market | USA |
 |
Medpace Holdings
MEDP
|
$ 424.0 | -1.1 % | $ 12.2 B | Nasdaq Global Select Market,SPB | USA |
 |
Co-Diagnostics
CODX
|
$ 2.53 | 31.09 % | $ 3.37 M | Nasdaq Capital Market | USA |
 |
Myriad Genetics
MYGN
|
$ 4.29 | 4.89 % | $ 397 M | Nasdaq Global Select Market,SPB | USA |
 |
NeoGenomics
NEO
|
$ 8.96 | -1.21 % | $ 1.15 B | Nasdaq Global Select Market,SPB | USA |
 |
National Research Corporation
NRC
|
$ 18.75 | 0.11 % | $ 420 M | Nasdaq Global Select Market | USA |
 |
Global Cord Blood Corporation
CO
|
- | - | $ 399 M | NYSE | China |
 |
Fluidigm Corporation
FLDM
|
- | 1.08 % | $ 308 M | Nasdaq Global Select Market | USA |
 |
Genetic Technologies Limited
GENE
|
- | - | $ 7.1 B | Nasdaq Capital Market |  Australia |
 |
Genetron Holdings Limited
GTH
|
- | 0.12 % | $ 80.1 M | Nasdaq Global Market | China |
 |
Natera
NTRA
|
$ 194.24 | -11.64 % | $ 19.1 B | Nasdaq Global Select Market,SPB | USA |
 |
DermTech
DMTK
|
- | -11.32 % | $ 2.94 M | Nasdaq Capital Market,SPB | USA |
 |
Charles River Laboratories International
CRL
|
$ 177.62 | -2.23 % | $ 8.8 B | NYSE,SPB | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
- | - | $ 10.7 B | Nasdaq Global Select Market | USA |
 |
Enzo Biochem
ENZ
|
- | -8.98 % | $ 14.8 K | NYSE | USA |
 |
Koninklijke Philips N.V.
PHG
|
$ 27.21 | 0.18 % | $ 25.8 B | NYSE |  Niderland |
 |
Exact Sciences Corporation
EXAS
|
- | - | $ 19.8 B | Nasdaq Capital Market,SPB | USA |
 |
Personalis
PSNL
|
$ 5.98 | -0.17 % | $ 534 M | Nasdaq Global Select Market | USA |
 |
Guardant Health
GH
|
$ 95.7 | 3.73 % | $ 12 B | Nasdaq Global Select Market,SPB | USA |
 |
Senseonics Holdings
SENS
|
$ 5.03 | -6.16 % | $ 210 M | NYSE American | USA |
 |
Soleno Therapeutics
SLNO
|
$ 52.95 | - | $ 2.69 B | Nasdaq Capital Market | USA |
 |
Heska Corporation
HSKA
|
- | - | $ 1.31 B | Nasdaq Capital Market,SPB | USA |
 |
ICON Public Limited Company
ICLR
|
$ 124.49 | -0.41 % | $ 10.3 B | Nasdaq Global Select Market,SPB |  Irlanda |
 |
Illumina
ILMN
|
$ 141.88 | 2.29 % | $ 22.6 B | Nasdaq Global Select Market,SPB | USA |
 |
Interpace Biosciences
IDXG
|
$ 1.95 | -2.5 % | $ 8.63 M | Nasdaq Global Select Market | USA |
 |
QIAGEN N.V.
QGEN
|
- | - | $ 10.6 B | NYSE | Niderland |
 |
Trinity Biotech plc
TRIB
|
$ 0.61 | 2.52 % | $ 219 M | Nasdaq Global Select Market | Irlanda |
 |
Twist Bioscience Corporation
TWST
|
$ 56.85 | -2.89 % | $ 3.4 B | Nasdaq Global Select Market,SPB | USA |
 |
Biomerica
BMRA
|
$ 2.15 | -2.05 % | $ 4.94 M | Nasdaq Capital Market | USA |
 |
Thermo Fisher Scientific
TMO
|
$ 465.0 | -1.99 % | $ 175 B | NYSE,SPB | USA |
 |
Laboratory Corporation of America Holdings
LH
|
$ 254.12 | -1.52 % | $ 21.1 B | NYSE,SPB | USA |
 |
Celcuity
CELC
|
$ 131.06 | 0.27 % | $ 6.13 B | Nasdaq Global Select Market | USA |
 |
Motus GI Holdings
MOTS
|
- | -34.28 % | $ 263 K | Nasdaq Global Select Market | Israel |
 |
Waters Corporation
WAT
|
$ 355.13 | 1.32 % | $ 21.1 B | NYSE,SPB | USA |
 |
Neogen Corporation
NEOG
|
$ 9.05 | -2.16 % | $ 1.96 B | Nasdaq Global Select Market,SPB | USA |
 |
Quest Diagnostics Incorporated
DGX
|
$ 187.39 | -1.82 % | $ 20.8 B | NYSE,SPB | USA |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.